Resources for coping with cancer during COVID-19. Learn More




Prostate cancer’s Achilles heel
Dr. Mike Cox is looking at how to stop prostate cancer cells from turning cholesterol into testosterone in advanced cancers. Prostate cancer uses testosterone to grow, so stopping its supply could be a way to kill them.

Using the body’s own cells to kill cancer
Dr. Ryan Wylie is researching whether immune cells could be used to kill cancer. If he can find a way, then drugs could make prostate cancer a chronic disease treated through medication, like high cholesterol.

More than testosterone
Dr. Éric Lévesque is using the latest technological advances to look into the role of male hormones in prostate cancer. The role of testosterone is well studied – but there are many others he is looking at to determine if they have a role as well.

Too old to be treated for prostate cancer?
Dr. Shabbir Alibhai is working with older, frailer men to see if daily tracking of their symptoms during treatment can lead to earlier intervention, and ideally help them live better and longer.

Surviving Cancer – now what?
Dr. Jennifer Jones has been researching prostate cancer survivorship since 1994. Read her story and watch her speak about her current research. Dr. Jennifer Jones discusses her recent research into prostate cancer survivorship.

Study could help doctors decide which patients need treatment
A big challenge in prostate cancer is figuring out which men need treatment right away. Drs. Paul Boutros and Thomas Kislinger are close to identifying whether men have aggressive prostate cancer that needs immediate action.
Hidden clue in blood could help fight against aggressive prostate cancer
Dr. Hansen He is working to develop a blood test to distinguish slow-growing and aggressive prostate cancer.
Seeking answers to an aggressive form of advanced prostate cancer
Drs. Paul Boutros and Hansen He are looking for better treatments for a deadly type of prostate cancer – neuroendocrine prostate cancer.
Close to a breakthrough on an aggressive form of advanced prostate cancer
Dr. Amina Zoubeidi and her team are coming close to developing a drug to treat neuroendocrine prostate cancer – a deadly form of prostate cancer for which there is no effective treatment.
Reflecting on 25 years of impact 
Dr. Laurence Klotz was part of the team that received Prostate Cancer Canada’s first research grant, which contributed to the development of active surveillance – an approach now used around the world.
Can you inherit prostate cancer? 
Dr. Danny Verspirini and his team are studying the BRCA2 gene and its connection to prostate cancer.
Uncovering prostate cancer mysteries in unexpected places 
Dr. Bapat Bharati and her team are looking at urine to see if there are markers in it for predict low-risk prostate cancer and cancer that is likely to spread.
Low oxygen in tumour cells leads to important discovery 
Dr. Paul Boutros and his team have discovered markers in tumour cells with low oxygen that could predict cancer progression.
From idea to possibility: Moving research from the lab to patient care 
Dr. Paul Rennie and his team are developing new ways to treat aggressive prostate cancer by targeting the cancer’s hormone receptors.


Blood markers that predict men who need more treatment 
Dr. Paul Toren and his team are researching the role of male – and female - hormones in the blood to predict which men would develop resistant cancer sooner.

Prostate Cancer Canada and Movember Foundation announce $4 million in new research funding 
Three leading Canadian research teams will work to look at ways to predict how well prostate cancer will respond to treatment based on men’s biological markers, specifically in their tumour cells and blood


Discovering clues to identifying aggressive prostate cancer 
Finding out what a man’s DNA tells us about his risk of developing advanced prostate cancer.


Can exercise help slow prostate cancer growth?
Dr. Kerry Courneya is studying whether exercise can reduce tumour growth and anxiety for men on active surveillance.


Predicting the risk of aggressive prostate cancer
Dr. Alexandre Zlotta is seeking to develop genetic testing for men with prostate cancer – something that already exists for other cancers

A blood test to help direct treatment
Dr. Alexander Wyatt discusses research looking into how men with prostate cancer that has spread outside the prostate can be identified for more effective treatments based on a blood test


Deadly prostate cancer and the BRCA gene
Dr. Robert Bristow talks about the relationship between a deadly form of prostate cancer and the BRCA2 gene.


Nanoparticles to help treat prostate cancer tumours with greater precision 
Dr. Gang Zheng is looking at nanoparticles, PEARLS, to target tumours more precisely

Viruses that can kill cancers
Dr. John Bell talks about the hope offered by immunotherapy – using viruses to kill cancer cells

Genetics and prostate cancer
Dr. Paul Boutros discusses the current state of genetic understanding as it relates to prostate cancer

Study of prostate cancer tumours published
Dr. Robert Bristow explains the hope offered by a genetic analysis of prostate cancer tumours published in the journal Nature

Drug in development for prostate cancers that resist treatment
Actor Eric McCormack interviews researchers who are developing a drug for those men with prostate cancer who have become resistant to treatment.

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive